Login
Super Investors Empery Asset Management, LP
EA

Empery Asset Management, LP

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$86.5M
Positions
32
Quarter ended
June 30, 2026
Filed
August 11, 2026

Reported portfolio value by quarter (7 quarters reported)

$113M $16.8M
Q4 21 Q2 22 Q4 25 Q2 26

$47.9M in Q4 2021 → $86.5M now. Hover for any quarter.

Holdings

As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
X4 Pharmaceuticals Inc 37.4% Trimmed 23% 6,930,591 $32.4M
Empery Digital Inc 12.1% Unchanged 2,930,345 $10.4M
Nervgen Pharma Corp 9.5% New 4,000,000 $8.24M
Precision Biosciences Inc 7.1% Trimmed 61% 776,093 $6.1M
Clene Inc 6.5% New 916,532 $5.64M
Annovis Bio Inc 5.2% New 2,401,476 $4.47M
Lantern Pharma Inc 4.1% New 842,669 $3.51M
AE Amc Entmt Hldgs Inc 3.8% New 1,714,043 $3.26M
Tenaya Therapeutics Inc 3.3% Trimmed 9.9% 3,863,115 $2.86M
OA One And One Green Technologi 1.8% New 761,706 $1.54M
Cyngn Inc 1.5% Trimmed 3.2% 927,059 $1.29M
VH Venu Hldg Corp 1.3% Trimmed 49% 512,818 $1.16M
Greenland Energy Co 1.0% New 1,000,000 $850K
Ur-energy Inc 1.0% Unchanged 620,136 $843K
Satellos Bioscience Inc 1.0% Trimmed 53% 107,100 $833K
Jaguar Uranium Corp 0.9% Unchanged 487,500 $814K
Cellectar Biosciences Inc 0.6% New 189,605 $527K
Scynexis Inc 0.6% New 126,451 $515K
Rein Therapeutics Inc 0.4% New 370,834 $386K
Btc Digital Ltd 0.3% New 350,877 $289K
Briacell Therapeutics Corp 0.3% Unchanged 300,000 $267K
Maris Tech Ltd 0.1% Unchanged 297,600 $58K
Parazero Technologies Ltd 0.1% Trimmed 60% 113,771 $55.3K
Duke Robotics Corp 0.1% New 35,000 $45.2K
Nutriband Inc 0.0% Unchanged 40,218 $40.2K
RT Renatus Tactical Acquis 0.0% Unchanged 50,000 $38K
Spectral Ai Inc 0.0% Unchanged 33,336 $18.5K
Nexera Technologies Ltd 0.0% Unchanged 360,577 $10.4K
CI Cea Industries Inc 0.0% Unchanged 500,000 $9.25K
Fgi Industries Ltd 0.0% Unchanged 83,928 $7.97K
Neurosense Therapeutics Ltd 0.0% Unchanged 100,402 $6.33K
Nexgel Inc 0.0% Unchanged 90,000 $3.47K

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 6 quarters.

Q2 2026

quarter ended June 30, 2026 · filed August 11, 2026

Company Action Shares changed Value of change % of portfolio
X4 Pharmaceuticals Inc Trimmed −2,013,527 −$9.4M 37.4%
Precision Biosciences Inc Trimmed −1,192,786 −$9.38M 7.1%
Nervgen Pharma Corp New +4,000,000 +$8.24M 9.5%
Clene Inc New +916,532 +$5.64M 6.5%
Annovis Bio Inc New +2,401,476 +$4.47M 5.2%
IP Imperial Pete Inc Exited −877,645 −$3.76M —
Lantern Pharma Inc New +842,669 +$3.51M 4.1%
AE Amc Entmt Hldgs Inc New +1,714,043 +$3.26M 3.8%
US U S Energy Corp Del Exited −1,917,844 −$1.7M —
Scynexis Inc Exited −1,847,826 −$1.69M —

Showing the 10 largest of 31 changes.

Q1 2026

quarter ended March 31, 2026 · filed May 08, 2026

Company Action Shares changed Value of change % of portfolio
Immuneering Corp Exited −2,674,950 −$17.6M —
IP Imperial Pete Inc Trimmed −2,305,306 −$9.87M 4.5%
Aduro Clean Technologies Inc Exited −571,046 −$5.92M —
VH Venu Hldg Corp New +1,007,729 +$3.34M 4.0%
Eos Energy Enterprises Inc Exited −249,726 −$2.86M —
Critical Metals Corp Trimmed −359,421 −$2.85M 1.3%
Surrozen Inc Exited −103,974 −$2.35M —
US U S Energy Corp Del New +1,917,844 +$1.7M 2.0%
Scynexis Inc New +1,847,826 +$1.69M 2.0%
Cyngn Inc New +957,784 +$1.59M 1.9%

Showing the 10 largest of 32 changes.

Q4 2025

quarter ended December 31, 2025 · filed February 11, 2026

Company Action Shares changed Value of change % of portfolio
X4 Pharmaceuticals Inc New +8,951,105 +$35.8M 31.6%
Immuneering Corp New +2,674,950 +$17.6M 15.5%
Empery Digital Inc New +2,930,345 +$13.4M 11.8%
IP Imperial Pete Inc New +3,182,951 +$11.5M 10.2%
Precision Biosciences Inc New +2,194,635 +$9.13M 8.1%
Aduro Clean Technologies Inc New +571,046 +$5.92M 5.2%
Tenaya Therapeutics Inc New +5,414,101 +$3.85M 3.4%
Critical Metals Corp New +491,460 +$3.41M 3.0%
Eos Energy Enterprises Inc New +249,726 +$2.86M 2.5%
Surrozen Inc New +103,974 +$2.35M 2.1%

Showing the 10 largest of 107 changes.

Q3 2022

quarter ended September 30, 2022 · filed November 14, 2022

Company Action Shares changed Value of change % of portfolio
Meta Materials Inc Exited −4,370,568 −$4.5M —
Unity Biotechnology Inc New +4,411,645 +$1.74M 10.4%
SL Sellas Life Sciences Group I Trimmed −619,518 −$1.25M 3.7%
GT Greenwave Technology Solutio New +618,844 +$1.07M 6.4%
Sobr Safe Inc New +248,430 +$666K 4.0%
MM Mind Medicine Mindmed Inc New +187,500 +$656K 3.9%
Applied Therapeutics Inc Exited −675,000 −$640K —
Medicenna Therapeutics Corp New +589,316 +$489K 2.9%
A Athenex Inc New +1,452,103 +$391K 2.3%
Benitec Biopharma Inc New +796,837 +$296K 1.8%

Showing the 10 largest of 32 changes.

Q2 2022

quarter ended June 30, 2022 · filed August 12, 2022

Company Action Shares changed Value of change % of portfolio
Meta Materials Inc New +4,370,568 +$4.5M 24.4%
SL Sellas Life Sciences Group I New +927,984 +$2.07M 11.2%
89bio Inc New +400,000 +$1.29M 7.0%
Brc Inc Exited −269,212 −$1.2M —
Sunshine Biopharma Inc Exited −450,450 −$1.1M —
VC The Valens Company Inc Exited −400,000 −$688K —
NI Nisun Intl Ent Dvpmt Gp Co L Exited −672,556 −$658K —
Applied Therapeutics Inc New +675,000 +$640K 3.5%
OI The Oncology Institute Inc Exited −70,733 −$504K —
Calithera Biosciences Inc Exited −775,925 −$313K —

Showing the 10 largest of 37 changes.

Q1 2022

quarter ended March 31, 2022 · filed May 16, 2022

Company Action Shares changed Value of change % of portfolio
Ispecimen Inc Exited −466,333 −$3.64M —
Opy Acquisition Corp I Exited −300,000 −$2.96M —
Ampio Pharmaceuticals Inc Exited −4,262,409 −$2.43M —
MR Mount Rainier Acquisition Corp Exited −200,000 −$2.03M —
CA Cactus Acquisition Cop I Ltd Exited −200,000 −$2.02M —
Regulus Therapeutics Inc Exited −5,074,251 −$1.6M —
AE Alset Ehome International Inc Exited −2,594,480 −$1.45M —
TB Tc Biopharm Holdings PLC New +2,823,528 +$1.38M 6.5%
Stran & Company Inc Exited −201,208 −$1.22M —
Brc Inc New +269,212 +$1.2M 5.7%

Showing the 10 largest of 76 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support